Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Leukemia 2Waldenstrom Macroglobulinemia 1Venous Thrombosis 1Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Ototoxicity 1Neoplastic Cells, Circulating 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Prolymphocytic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Inflammation 1Hodgkin Disease 1Hemangioma, Cavernous, Central Nervous System 1Heart Failure 1

Interventions

Electrocardiography 3Echocardiography 3Surveys and Questionnaires 2Nutrition Assessment 2Carvedilol 2ziprasidone 1sacubitril and valsartan sodium hydrate drug combination 1candesartan 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vascular Stiffness 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sodium Chloride 1Simendan 1Sevelamer 1Rocuronium 1Resistance Training 1Pulse Wave Analysis 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Palliative Care 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Metoprolol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Heart Failure × Atorvastatin × Clear all
NCT02943590 2025-05-15

STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)

Massachusetts General Hospital

Phase 2 Completed
300 enrolled 13 charts

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡